| Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120) |
|---|
| 01/23/2002 | EP1049744B1 Asymmetric cyanine dye quenchers |
| 01/23/2002 | EP0711292B1 Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity |
| 01/23/2002 | CN1332743A Cell adhesion-inhibiting antinflammatory compounds |
| 01/22/2002 | US6340752 Cleavage of thio group from carbonyl and conversion to lactam ester |
| 01/22/2002 | US6340683 Selective NPY (Y5) antagonists (triazines) |
| 01/17/2002 | WO2002004444A2 Heterocycle carboxamides as antiviral agents |
| 01/17/2002 | WO2002004409A2 Tetrahydrobenzothiazole analogues as neuroprotective agents |
| 01/17/2002 | US20020006944 Anticoagulants |
| 01/17/2002 | US20020006941 p53 inhibitors and therapeutic use of the same |
| 01/17/2002 | US20020006921 Dopaminergic agent |
| 01/17/2002 | CA2415815A1 Tetrahydrobenzothiazole analogues as neuroprotective agents |
| 01/16/2002 | EP1171442A1 Xanthine derivatives and analogs as cell signalling inhibitors |
| 01/16/2002 | EP1171122A1 Pyrrolidine modulators of chemokine receptor activity |
| 01/16/2002 | CN1331690A 4-(caminomethyl)-piperidine benzamides for treating gastrointestinal disorders |
| 01/16/2002 | CN1331591A Piperidines as CCR5 modulators |
| 01/16/2002 | CN1077886C Amidino derivatives useful as nitric oxide synthase inhibitors |
| 01/15/2002 | CA2039826C Spiro bridged and unbridged heterocyclic compounds |
| 01/10/2002 | WO2002002562A2 Heteropolycyclic inhibitors |
| 01/10/2002 | WO2002002549A1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/10/2002 | WO2002002512A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2001036425A3 Imidazole compounds used as phosphodiesterase vii inhibitors |
| 01/10/2002 | US20020004501 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders |
| 01/10/2002 | US20020004500 Drug mixture for cardiovascular disorders |
| 01/10/2002 | DE10019714A1 Salze von bicyclischen, N-acylierten Imidazo-3-aminen und Imidazo-5-aminen Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines |
| 01/10/2002 | CA2414885A1 Heteropolycyclic inhibitors |
| 01/10/2002 | CA2412287A1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/10/2002 | CA2410651A1 Compounds to treat alzheimer's disease |
| 01/09/2002 | EP1170273A1 Alkynic compounds, their use as monomers in vacuum deposition polymerisation, thin films formed from these polymers and their use in electroluminescent devices |
| 01/09/2002 | CN1330655A Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 01/09/2002 | CN1330654A 4,5-pyrrolo-oxindoles |
| 01/08/2002 | US6337395 Selenium derivatives of porphryn |
| 01/03/2002 | WO2002000658A1 Cyclic gmp-specific phosphodiesterase inhibitors |
| 01/03/2002 | WO2002000612A1 Glucagon antagonists/inverse agonists |
| 01/03/2002 | WO2002000223A1 Use of potassium channel agonists for reducing fat food comsumption |
| 01/03/2002 | WO2002000222A1 Use of potassium channel agonists for the treatment of cancer |
| 01/03/2002 | WO2001044247A3 Agents and methods for the treatment of proliferative diseases |
| 01/03/2002 | US20020002173 E. g., 6-(3-chlorophenyl)-1,4-dihydro-4,4-dimethyl-2H-thieno-(2,3-d)(1,3)oxazine-2 -one; agonists and antagonists of the progesterone receptor; inducing contraception and treating or preventing benign or malignant neoplastic diseases |
| 01/03/2002 | US20020002165 Growth hormone secretagogues useful for treatment/prevention of osteoporosis |
| 01/03/2002 | CA2411552A1 Glucagon antagonists/inverse agonists |
| 01/02/2002 | EP1167373A1 Ferrocenyldiphosphine-ruthenium complexes and a hydrogenation process of exocyclic double bond of d-thiophene to d-thiophane |
| 01/02/2002 | EP1167369A1 Novel thiazolobenzimidazole derivatives |
| 01/02/2002 | EP1165566A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 01/02/2002 | EP1165563A1 Bicyclic heterocycles, method for producing them and their use as herbicides and pharmaceutical agents |
| 01/02/2002 | EP1165545A1 Novel compounds |
| 01/02/2002 | EP1165532A1 Antibacterial agents |
| 01/02/2002 | EP1165514A1 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors |
| 01/02/2002 | EP0912553B1 BENZO[g]QUINOLINE DERIVATIVES |
| 01/02/2002 | CN1329601A New benzimidazolone-benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
| 01/02/2002 | CN1328824A Compound for curing female sexual disorder |
| 12/27/2001 | WO2001057042A3 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 12/26/2001 | CN1328455A Use of N-substituted azabicycloalkane derivatives for treating diseases of central nervous system |
| 12/25/2001 | US6333296 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them |
| 12/25/2001 | CA2209313C Heterocycle-fused thiazole derivatives |
| 12/20/2001 | US20010053783 Central nervous system disorders |
| 12/19/2001 | EP1164128A1 4-Cyanophenyliminoheterocycles |
| 12/19/2001 | EP1163233A1 Fused 1,4-thiazine-2-carbonitrile derivatives, their preparation and use |
| 12/19/2001 | EP0983063B1 Pharmaceutical composition containing uscharin |
| 12/18/2001 | US6331623 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 12/18/2001 | US6331507 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 12/13/2001 | WO2001025241A3 Fused 1-(2,6-dichloro-4-trifluoromethylphenyl)-pyrazoles, the synthesis thereof and the use thereof as pesticides |
| 12/13/2001 | US20010051620 Tricyclic protein kinase inhibitors |
| 12/13/2001 | DE10101324C1 New 1-(dimercaptoalkyl)-quinazoline-2,4(1H,3H)-diones, are stable matrix metalloproteinase inhibitors useful e.g. for treating rheumatism, tumor metastasis or sunburn |
| 12/12/2001 | EP1161233A2 Lxr modulators |
| 12/12/2001 | CN1326473A Supported group 8-10 transition metal olefin polymerization catalysts |
| 12/11/2001 | US6329542 Preparation of (S)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes |
| 12/11/2001 | US6329375 Tricyclic quinoxaline derivatives as protein tyrosine kinase inhibitors |
| 12/11/2001 | US6329367 Nervous system disorders and cardiovascular disorders |
| 12/06/2001 | WO2001036426B1 Pyridinones to treat and prevent bacterial infections |
| 12/05/2001 | EP1159280A2 Thiazoloindolinone compounds |
| 12/05/2001 | EP0605493B1 THIADIAZOLO (4,3-a)PYRIDINE DERIVATIVES, METHODS OF PREPARING THEM AND DRUGS CONTAINING THEM |
| 12/05/2001 | CN1325309A Compounds, compositions and method for treating or preventing viral infections and associated diseases |
| 12/04/2001 | US6326378 Use of thiadiazolo[4,3-a]pyridine derivatives |
| 11/29/2001 | WO2001090101A1 Arylmethylamine derivatives for use as tryptase inhibitors |
| 11/29/2001 | WO2001090094A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 11/29/2001 | WO2001090093A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 11/29/2001 | WO2001090092A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 11/29/2001 | WO2001090091A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 11/29/2001 | WO2001090090A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 11/29/2001 | WO2001090081A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 11/29/2001 | WO2001089526A1 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
| 11/29/2001 | WO2000055159A3 Substituted aza-oxindole derivatives |
| 11/29/2001 | US20010046989 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 11/29/2001 | CA2408791A1 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
| 11/29/2001 | CA2408783A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 11/28/2001 | EP1157024A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors |
| 11/28/2001 | EP1157013A1 Polycyclic thiazole-2-ylides amines, method for the production thereof and their utilization as medicaments |
| 11/28/2001 | EP0914129B1 Use of aspirochlorine or derivatives thereof as immunosuppressive agents |
| 11/27/2001 | US6323201 Compounds for inhibition of ceramide-mediated signal transduction |
| 11/27/2001 | US6323200 The compounds are immunomodulators and induce cytokine biosynthesis, including interferon and/or tumor biosynthesis, necrosis factor, and inhibit the t-helper-type 2 immune response. |
| 11/27/2001 | US6323038 Diagnostic reagent for complications associated with diabetes or renal failure |
| 11/22/2001 | WO2001087892A1 Crf receptor antagonists |
| 11/22/2001 | WO2001087886A1 Crf receptor antagonists and methods relating thereto |
| 11/22/2001 | WO2001087883A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 11/22/2001 | WO2001087844A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 11/22/2001 | WO2001030781A3 INHIBITORS OF αLβ2 MEDIATED CELL ADHESION |
| 11/22/2001 | US20010044539 (2S,3Z)-2-amino-5-(6,7,8,9-tetrahydro-3-oxo-3H,5H -(1,2,4)oxadiazolo(4,3-a)azepin-5-yl)-3-pentenoic acid, for example |
| 11/21/2001 | EP1156050A2 Substituted tricyclics useful in sPLA2 induced diseases |
| 11/21/2001 | EP1155010A1 Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s |
| 11/21/2001 | EP1154992A1 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production |
| 11/21/2001 | EP0745081B1 indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase |